Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
Australia
Monash Health, Clayton, Victoria St. Vincent's Hospital Melbourne, Fitzroy, Victoria The Alfred Hospital, Melbourne, Victoria Hollywood Private Hospital, Nedlands, Western Australia Royal Perth Hospital, Perth, Western Australia